Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Allergy News
June 2026 Ophthalmic News Briefs
UK-based Rayner announced June 1 the launch of Ophteis Cohesive, a new OVD formulated with a high molecular weight to optimize space creation and ease of removal. Ophteis Cohesive is packaged at 1....
Harrow Relaunches Verkazia in the US for Vernal Keratoconjunctivitis
Harrow reported June 10 that it had relaunched Verkazia (cyclosporine ophthalmic emulsion, 0.1%) in the US for the treatment of vernal keratoconjunctivitis (VKC). VKC is a serious allergic eye dise...
Emerging Companies Pursuing Ophthalmic Indications, March 2026
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
US FDA Gives Green Light to Phase II/III Trial of NexEos Bio’s Vernal Keratoconjunctivitis Candidate
NexEos Bio, of Malvern, Pennsylvania, reported on Feb. 19 that the US FDA had signed off on its investigational new drug (IND) application, allowing the company to proceed with a Phase II/III trial...
Clinical Trial Updates for Ophthalmic Candidates , January 2026
Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.